Innoviva, Inc. 13D and 13G filings for Armata Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-03-12 5:49 pm Unchanged |
2025-03-12 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
64,178,259 85.200% |
0 (Unchanged) |
Filing |
2024-11-14 4:17 pm Unchanged |
2024-11-12 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
64,178,259 85.200% |
0 (Unchanged) |
Filing |
2024-03-04 5:35 pm Unchanged |
2024-03-04 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
64,178,259 85.300% |
0 (Unchanged) |
Filing |
2023-07-11 08:27 am Unchanged |
2023-07-10 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
64,178,259 85.300% |
0 (Unchanged) |
Filing |
2023-01-10 5:12 pm Purchase |
2023-01-10 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
64,178,259 85.300% |
19,736,843![]() (+44.41%) |
Filing |
2022-07-11 5:27 pm Sale |
2022-07-07 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
100 100.000% |
-57,345,694![]() (-100.00%) |
Filing |
2022-05-23 8:55 pm Unchanged |
2022-05-23 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
57,345,794 74.930% |
0 (Unchanged) |
Filing |
2022-04-01 4:50 pm Purchase |
2022-03-31 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
44,441,416 80.100% |
8,077,812![]() (+22.21%) |
Filing |
2022-03-15 09:00 am Unchanged |
2022-03-15 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
57,345,794 74.930% |
0 (Unchanged) |
Filing |
2022-02-18 8:47 pm Unchanged |
2022-02-17 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
57,345,794 75.150% |
0 (Unchanged) |
Filing |
2022-02-11 3:15 pm Purchase |
2022-02-09 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
36,363,604 76.700% |
5,422,188![]() (+17.52%) |
Filing |
2022-02-01 6:34 pm Unchanged |
2022-02-01 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
57,345,794 75.150% |
0 (Unchanged) |
Filing |
2021-11-01 09:27 am Purchase |
2021-10-28 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
30,941,416 73.800% |
30,941,416![]() (New Position) |
Filing |
2021-06-11 5:37 pm Purchase |
2021-06-11 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
57,345,794 75.500% |
29,345,794![]() (+104.81%) |
Filing |
2021-04-05 5:07 pm Sale |
2021-04-01 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
0 0.000% |
-29,729,294![]() (Position Closed) |
Filing |
2021-03-17 5:17 pm Purchase |
2021-03-17 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
29,729,294 74.700% |
8,571,870![]() (+40.51%) |
Filing |
2021-01-27 5:30 pm Purchase |
2021-01-26 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
21,157,424 68.000% |
3,735,824![]() (+21.44%) |
Filing |
2020-08-31 3:10 pm Unchanged |
2020-08-27 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
28,000,000 67.800% |
0 (Unchanged) |
Filing |
2020-06-12 5:30 pm Purchase |
2020-06-11 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
28,000,000 67.800% |
28,000,000![]() (New Position) |
Filing |